According to Johnson & Johnson’s (NYSE: JNJ) SEC Filings, Joaquin Duato has assumed the role of CEO, effective January 3, 2022. Previously, Duato was the Vice-Chairman of the company’s Executive Committee. He has also been appointed to JNJ’s Board. Additionally, former CEO and Chairman Alex Gorsky has transitioned to Executive Chairman of the multinational company, also effective January 3. About Johnson & Johnson New Jersey-based Johnson & Johnson develops medical devices, pharmaceuticals, and consumer packaged goods. The company has 250 subsidiaries with operations in 60 countries and products sold in over 175 countries. Its brands include Band-Aid, Tylenol, Neutrogena, Clean & Clear and Acuvue, among others.
https://www.tipranks.com/news/joaquin-duato-becomes-ceo-of-johnson-johnson-joins-board?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Abr 2022 até Mai 2022 Click aqui para mais gráficos Johnson and Johnson.
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Mai 2021 até Mai 2022 Click aqui para mais gráficos Johnson and Johnson.